Teva Pharmaceutical Indus... (TEVA)

NYSE: TEVA · Real-Time Price · USD

15.63

0.12 (0.77%)

At close: May 01, 2025, 3:59 PM

15.60

-0.22%

After-hours: May 01, 2025, 07:47 PM EDT

Teva Pharmaceutical Industries Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.3B	3.23B	2.8B	2.17B	2.18B	1.98B	1.78B	963M	988M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	17M	10M
Long-Term Investments	n/a	8M	n/a	n/a	n/a	n/a	58M	25M	88M
Other Long-Term Assets	462M	463M	441M	515M	538M	591M	673M	907M	1.15B
Receivables	3.06B	3.41B	3.7B	4.53B	4.58B	5.68B	5.82B	7.13B	7.52B
Inventory	3.01B	4.02B	3.83B	3.82B	4.4B	4.42B	4.73B	4.92B	4.95B
Other Current Assets	3.19B	575M	559M	986M	899M	521M	560M	1.27B	2.13B
Total Current Assets	12.55B	12.48B	12.05B	12.57B	13.01B	13.46B	13.79B	15.38B	16.96B
Property-Plant & Equipment	4.95B	6.15B	6.16B	6.48B	6.85B	6.95B	6.87B	7.67B	8.07B
Goodwill & Intangibles	19.57B	22.56B	23.9B	27.51B	29.55B	36.08B	38.92B	46.05B	65.9B
Total Long-Term Assets	26.77B	30.99B	31.95B	35.09B	37.63B	44.01B	46.89B	55.23B	75.93B
Total Assets	39.33B	43.48B	44.01B	47.67B	50.64B	57.47B	60.68B	70.61B	92.89B
Account Payables	2.2B	2.6B	1.89B	1.69B	1.76B	1.72B	1.85B	2.07B	2.16B
Deferred Revenue	n/a	n/a	1.45B	7.01B	7.29B	8.72B	9.45B	11.44B	725M
Short-Term Debt	1.78B	1.67B	2.11B	1.43B	3.19B	2.35B	2.22B	3.65B	3.28B
Other Current Liabilities	6.02B	5.2B	2.42B	7.24B	7.42B	8.8B	9.38B	11.66B	12.2B
Total Current Liabilities	12.8B	12.25B	11.47B	11.03B	13.16B	13.67B	14.32B	17.92B	18.52B
Long-Term Debt	16.3B	18.16B	19.1B	21.62B	22.73B	24.56B	26.7B	28.83B	32.52B
Other Long-Term Liabilities	4.03B	4.02B	3.85B	2.58B	2.24B	2.64B	1.73B	1.84B	1.64B
Total Long-Term Liabilities	20.81B	23.11B	23.85B	25.39B	26.41B	28.73B	30.57B	33.95B	39.38B
Total Liabilities	33.61B	35.35B	35.31B	36.42B	39.58B	42.41B	44.89B	51.87B	57.9B
Total Debt	18.08B	20.15B	21.56B	23.46B	26.4B	27.34B	28.92B	32.48B	35.8B
Common Stock	n/a	57M	57M	57M	57M	56M	56M	54M	54M
Retained Earnings	-15.17B	-13.53B	-12.88B	-10.53B	-10.95B	-6.96B	-5.96B	-3.8B	13.61B
Comprehensive Income	-3.15B	-2.7B	-2.84B	-2.68B	-2.4B	-2.31B	-2.46B	-1.85B	-3.16B
Shareholders Equity	5.38B	7.51B	7.9B	10.28B	10.03B	13.97B	14.71B	17.36B	33.34B
Total Investments	n/a	8M	n/a	n/a	n/a	n/a	58M	42M	98M